GLP1R and rheumatoid arthritis: Treatment of cultured human islets with exendin-4 inhibits activation of the NF-κB pathway that results in the down-regulation of inflammatory genes, suggesting that GLP-1 RA therapy can reduce insulitis and promote β cell survival [139].